
- BioPharm International-11-15-2017
- Volume 2017 eBook
- Issue 3
Achieving Intensification and Flexibility in Virus Purification with Next-Generation Chromatography Tools
This article discusses the potential of using high-productivity membrane chromatography to achieve intensified and flexible virus manufacturing.
Most vaccines available today are still manufactured using antiquated, low-yield, and labor-intensive process technologies in capital-intensive facilities. This lack of manufacturing flexibility drives high cost of goods, diminishes affordability for developing countries, and reduces the market incentive to address smaller patient populations. Improved manufacturing technologies can enable more efficient and cost-effective processes. This article discusses the potential of using high-productivity membrane chromatography to achieve intensified and flexible virus manufacturing.
Download
eBook.
Article Details
Pharmaceutical Technology and BioPharm International
eBook: Vaccine Development and Manufacturing 2017
November 2017
Pages: 39-44
Citation
When referring to this article, please cite it as R. Jacquemart et al., “Achieving Intensification and Flexibility in Virus Purification with Next-Generation Chromatography Tools,” Pharmaceutical Technology and BioPharm International Vaccine Development and Manufacturing 2017 eBook (November 2017).
Articles in this issue
almost 8 years ago
Designing and Operating Flexible, High-Containment Vaccine Manufacturingalmost 8 years ago
Therapeutic Vaccines Target Cancer and Other Viral-Induced Diseasesalmost 8 years ago
Cold Chain: Delivering Vaccines to Patientsalmost 8 years ago
Using Human Challenge Trials to Develop Flu Vaccinesalmost 8 years ago
Moving to Closed Systems for Aseptic Processingalmost 8 years ago
Making Vaccines Accessiblealmost 8 years ago
Accelerating Vaccine Development and ManufacturingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.